In the 21st century, novel therapeutics will be established. Controlled drug delivery has already been commercialized for limited uses. Gene therapy in human patients is being investigated experimentally. Furthermore, robotic surgery systems, as well as computer-aided surgery navigation systems, are commercially available. Tissue engineering was first proposed in the 1980s by a chemist, R. Langer, and a surgeon, J. P. Vacanti1. The key technology is the use of biodegradable polymer scaffolds, preformed in the target tissue shape, for cell seeding2, as demonstrated in the well-publicized reconstruction of cartilage tissues for the growth of human ears on mice. By combining preformed biodegradable polymer scaffolds and specific cell types, various tissues including cartilage, bone, and blood vessels have been reconstructed, although, so far, therapeutic use has been very limited.
ハーバード大学のベスイスラエル病院のグループの研究で「Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis （怒りの爆発は急性の心臓発作の引き金になる：体系的再調査とメタ解析）」がタイトルだ。..................
＞ TWIns was established as a joint research facility between Tokyo Women's Medical University and Waseda University, and it stands for Tokyo Women's Medical University and Waseda University Joint Institution for Advanced Biomedical ...
